TIAA CREF Investment Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $296K | Hold |
41,636
| – | – | ﹤0.01% | 2779 |
|
|
2018
Q4 | $356K | Sell |
41,636
-620
| -1% | -$5.3K | ﹤0.01% | 2710 |
|
|
2018
Q3 | $846K | Sell |
42,256
-3,718
| -8% | -$74.4K | ﹤0.01% | 2502 |
|
|
2018
Q2 | $1.19M | Buy |
45,974
+3,886
| +9% | +$100K | ﹤0.01% | 2421 |
|
|
2018
Q1 | $1.01M | Buy |
42,088
+3,939
| +10% | +$94.2K | ﹤0.01% | 2443 |
|
|
2017
Q4 | $1.29M | Sell |
38,149
-24,502
| -39% | -$830K | ﹤0.01% | 2340 |
|
|
2017
Q3 | $1.33M | Buy |
62,651
+17,592
| +39% | +$372K | ﹤0.01% | 2380 |
|
|
2017
Q2 | $788K | Sell |
45,059
-935
| -2% | -$16.4K | ﹤0.01% | 2657 |
|
|
2017
Q1 | $805K | Sell |
45,994
-1,872
| -4% | -$32.8K | ﹤0.01% | 2620 |
|
|
2016
Q4 | $809K | Sell |
47,866
-6,170
| -11% | -$104K | ﹤0.01% | 2651 |
|
|
2016
Q3 | $887 | Sell |
54,036
-760
| -1% | -$12 | ﹤0.01% | 2604 |
|
|
2016
Q2 | $830K | Buy |
54,796
+18,499
| +51% | +$280K | ﹤0.01% | 2614 |
|
|
2016
Q1 | $525K | Buy |
36,297
+1,598
| +5% | +$23.1K | ﹤0.01% | 2770 |
|
|
2015
Q4 | $983K | Hold |
34,699
| – | – | ﹤0.01% | 2593 |
|
|
2015
Q3 | $581K | Buy |
34,699
+12,633
| +57% | +$212K | ﹤0.01% | 2838 |
|
|
2015
Q2 | $579K | Buy |
22,066
+12,569
| +132% | +$330K | ﹤0.01% | 2921 |
|
|
2015
Q1 | $166K | Hold |
9,497
| – | – | ﹤0.01% | 3071 |
|
|
2014
Q4 | $165K | Sell |
9,497
-78
| -0.8% | -$1.36K | ﹤0.01% | 3106 |
|
|
2014
Q3 | $178K | Buy |
9,575
+1,240
| +15% | +$23.1K | ﹤0.01% | 3091 |
|
|
2014
Q2 | $152K | Buy |
+8,335
| New | +$152K | ﹤0.01% | 3085 |
|